Fractures in The 340B Program

The 340B Program remains controversial. Hospitals and other Covered Entities (providers qualified to buy drugs at 340B prices) that benefit...

The Part D Squeeze

[DISCLAIMER: This isn’t a legal analysis. We’ve simplified provisions in the law where we could while still describing the intent...

Shopping for Healthcare Deals

New price transparency rules set by the government are an opportunity to save money. Not for hospitals, not for payers,...

Are PBMs Actually Pharma’s Friends?

Pharmacy Benefit Managers (PBMs) have received a lot of negative publicity lately. Here is some more: A new whistleblower lawsuit...

Manufacturers Restricting 340B Sales to Contract Pharmacies

  • Abbvie
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • UCB
  • United Therapeutics
  • and more…